Stroke rehabilitation in adults

on wrist and hand splints) • advice on identifying and managing triggers of spasticity. [2023] 1.15.5 For people who have focal spasticity of the upper limb after stroke, consider treatment with either Dysport at a dose of up to 1,000 units per treatment or with Xeomin at a dose of up to 400 units per treatment, unless they are already receiving a different type or dose of botulinum toxin A. Ensure that: • the dose is spread across appropriate injection sites in the affected limb and • people do not receive more than 1 treatment every 3 months and • response to the treatment is monitored and it is stopped if it is not effective. For people who are already receiving botulinum toxin A of a different type or dose, continue with this treatment if it is effective. [2023] 1.15.6 Consider a trial of NMES, functional electrical stimulation (FES) or transcutaneous electrical nerve stimulation (TENS) for people after stroke with focal spasticity. [2023] 1.15.7 Consider oral baclofen for people after stroke with generalised spasticity but monitor closely for adverse effects. [2023] 1.15.8 Refer people after stroke to a specialist spasticity service if: • they have ongoing spasticity that has not
